Process development and safety evaluation of ABCB5(+) limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

BACKGROUND: While therapeutic success of the limbal tissue or cell transplantation to treat severe cases of limbal stem cell (LSC) deficiency (LSCD) strongly depends on the percentage of LSCs within the transplanted cells, prospective LSC enrichment has been hampered by the intranuclear localization...

Descripción completa

Detalles Bibliográficos
Autores principales: Norrick, Alexandra, Esterlechner, Jasmina, Niebergall-Roth, Elke, Dehio, Ulf, Sadeghi, Samar, Schröder, Hannes M., Ballikaya, Seda, Stemler, Nicole, Ganss, Christoph, Dieter, Kathrin, Dachtler, Ann-Kathrin, Merz, Patrick, Sel, Saadettin, Chodosh, James, Cursiefen, Claus, Frank, Natasha Y., Auffarth, Gerd U., Ksander, Bruce, Frank, Markus H., Kluth, Mark A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980611/
https://www.ncbi.nlm.nih.gov/pubmed/33741066
http://dx.doi.org/10.1186/s13287-021-02272-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980611/
https://www.ncbi.nlm.nih.gov/pubmed/33741066
http://dx.doi.org/10.1186/s13287-021-02272-2

Ejemplares similares